ZA200300418B - Method of treating cardiovascular disease. - Google Patents
Method of treating cardiovascular disease.Info
- Publication number
- ZA200300418B ZA200300418B ZA200300418A ZA200300418A ZA200300418B ZA 200300418 B ZA200300418 B ZA 200300418B ZA 200300418 A ZA200300418 A ZA 200300418A ZA 200300418 A ZA200300418 A ZA 200300418A ZA 200300418 B ZA200300418 B ZA 200300418B
- Authority
- ZA
- South Africa
- Prior art keywords
- cardiovascular disease
- treating cardiovascular
- treating
- disease
- cardiovascular
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21211700P | 2000-06-16 | 2000-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200300418B true ZA200300418B (en) | 2004-04-15 |
Family
ID=22789625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200300418A ZA200300418B (en) | 2000-06-16 | 2003-01-15 | Method of treating cardiovascular disease. |
Country Status (19)
Country | Link |
---|---|
US (1) | US20020013335A1 (zh) |
EP (1) | EP1292302A2 (zh) |
JP (1) | JP2003535899A (zh) |
KR (1) | KR20030010710A (zh) |
CN (1) | CN1436076A (zh) |
AR (1) | AR028959A1 (zh) |
AU (2) | AU6844601A (zh) |
BR (1) | BR0111601A (zh) |
CA (1) | CA2412636A1 (zh) |
CZ (1) | CZ20024115A3 (zh) |
EA (1) | EA200300027A1 (zh) |
HU (1) | HUP0301244A3 (zh) |
IL (1) | IL153405A0 (zh) |
MX (1) | MXPA02012410A (zh) |
NO (1) | NO20026008L (zh) |
NZ (1) | NZ523114A (zh) |
PL (1) | PL365455A1 (zh) |
WO (1) | WO2001097809A2 (zh) |
ZA (1) | ZA200300418B (zh) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1296043C (zh) | 2001-02-19 | 2007-01-24 | 诺瓦提斯公司 | 式i的雷帕霉素化合物在制备用于治疗实体瘤的药物组合物中的用途 |
US6641611B2 (en) | 2001-11-26 | 2003-11-04 | Swaminathan Jayaraman | Therapeutic coating for an intravascular implant |
US20040137066A1 (en) * | 2001-11-26 | 2004-07-15 | Swaminathan Jayaraman | Rationally designed therapeutic intravascular implant coating |
EA011488B1 (ru) | 2002-02-01 | 2009-04-28 | Ариад Джин Терапьютикс, Инк. | Фосфорсодержащие соединения и их получение |
US20030176455A1 (en) * | 2002-03-13 | 2003-09-18 | Wyeth | Method of inhibiting cell death |
AU2003254168A1 (en) * | 2002-07-30 | 2004-02-16 | Wyeth | Parenteral formulations containing a rapamycin hydroxyester |
EP1635830B1 (en) * | 2002-09-17 | 2008-11-05 | Wyeth | Granulate formulation of the rapamycin ester cci-779 |
WO2004060283A2 (en) | 2002-12-16 | 2004-07-22 | Nitromed, Inc. | Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
AR042938A1 (es) | 2003-02-06 | 2005-07-06 | Wyeth Corp | Uso del cci-779 en el tratamiento de la fibrosis hepatica |
US7728033B2 (en) | 2003-05-05 | 2010-06-01 | Clinigene International Private Limited | Mycophenolate mofetil in diabetic nephropathy |
US7220755B2 (en) | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
DE102004019845A1 (de) * | 2004-03-29 | 2005-10-20 | Krka Tovarna Zdravil D D | Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung |
US20050232965A1 (en) * | 2004-04-15 | 2005-10-20 | Robert Falotico | Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |
DE602005025755D1 (de) * | 2004-06-04 | 2011-02-17 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
CN100435755C (zh) * | 2004-07-27 | 2008-11-26 | 微创医疗器械(上海)有限公司 | 药物洗脱支架 |
EP1656941A1 (en) * | 2004-11-09 | 2006-05-17 | Clinigene International Private Limited | Compositions for the treatment of diabetic nephropathy |
GB0503936D0 (en) | 2005-02-25 | 2005-04-06 | San Raffaele Centro Fond | Method |
CN100384416C (zh) * | 2006-03-20 | 2008-04-30 | 杨军 | 一种用于治疗心血管疾病的药物组合物 |
US8414909B2 (en) * | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
CN102803189B (zh) | 2010-03-15 | 2016-01-20 | 埃克森美孚化学专利公司 | 用于生产醇的方法 |
EP2906214A1 (en) * | 2012-10-12 | 2015-08-19 | The Board of Regents of The University of Texas System | Use of mtor inhibitors to treat vascular cognitive impairment |
US10098871B2 (en) * | 2013-03-15 | 2018-10-16 | Leslie B. Gordon | Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis |
CA2933908C (en) | 2013-12-31 | 2024-01-30 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
CN105997940A (zh) * | 2016-05-11 | 2016-10-12 | 中国人民解放军第三军医大学 | 炎症微环境响应性纳米药物、其制备方法及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
US5373014A (en) * | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
US5563145A (en) * | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
GB9606452D0 (en) * | 1996-03-27 | 1996-06-05 | Sandoz Ltd | Organic compounds |
PT994697E (pt) * | 1997-06-13 | 2005-02-28 | Wyeth Corp | Formulacoes de rapamicina para administracao oral |
US6015809A (en) * | 1998-08-17 | 2000-01-18 | American Home Products Corporation | Photocyclized rapamycin |
-
2001
- 2001-06-13 US US09/880,295 patent/US20020013335A1/en not_active Abandoned
- 2001-06-14 EP EP01946387A patent/EP1292302A2/en not_active Ceased
- 2001-06-14 EA EA200300027A patent/EA200300027A1/ru unknown
- 2001-06-14 HU HU0301244A patent/HUP0301244A3/hu unknown
- 2001-06-14 AU AU6844601A patent/AU6844601A/xx active Pending
- 2001-06-14 PL PL01365455A patent/PL365455A1/xx not_active Application Discontinuation
- 2001-06-14 CZ CZ20024115A patent/CZ20024115A3/cs unknown
- 2001-06-14 IL IL15340501A patent/IL153405A0/xx unknown
- 2001-06-14 WO PCT/US2001/019179 patent/WO2001097809A2/en not_active Application Discontinuation
- 2001-06-14 AU AU2001268446A patent/AU2001268446B2/en not_active Ceased
- 2001-06-14 MX MXPA02012410A patent/MXPA02012410A/es not_active Application Discontinuation
- 2001-06-14 CA CA002412636A patent/CA2412636A1/en not_active Abandoned
- 2001-06-14 BR BR0111601-0A patent/BR0111601A/pt not_active IP Right Cessation
- 2001-06-14 NZ NZ523114A patent/NZ523114A/en unknown
- 2001-06-14 JP JP2002503293A patent/JP2003535899A/ja active Pending
- 2001-06-14 KR KR1020027017036A patent/KR20030010710A/ko not_active Application Discontinuation
- 2001-06-14 CN CN01811212A patent/CN1436076A/zh active Pending
- 2001-06-15 AR ARP010102877A patent/AR028959A1/es not_active Application Discontinuation
-
2002
- 2002-12-13 NO NO20026008A patent/NO20026008L/no not_active Application Discontinuation
-
2003
- 2003-01-15 ZA ZA200300418A patent/ZA200300418B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20026008D0 (no) | 2002-12-13 |
WO2001097809A2 (en) | 2001-12-27 |
MXPA02012410A (es) | 2003-04-25 |
HUP0301244A3 (en) | 2005-01-28 |
EA200300027A1 (ru) | 2003-06-26 |
CA2412636A1 (en) | 2001-12-27 |
NZ523114A (en) | 2004-07-30 |
NO20026008L (no) | 2002-12-13 |
AR028959A1 (es) | 2003-05-28 |
BR0111601A (pt) | 2003-07-01 |
KR20030010710A (ko) | 2003-02-05 |
WO2001097809A3 (en) | 2002-05-10 |
AU6844601A (en) | 2002-01-02 |
CZ20024115A3 (cs) | 2003-06-18 |
US20020013335A1 (en) | 2002-01-31 |
PL365455A1 (en) | 2005-01-10 |
HUP0301244A2 (hu) | 2003-08-28 |
IL153405A0 (en) | 2003-07-06 |
JP2003535899A (ja) | 2003-12-02 |
CN1436076A (zh) | 2003-08-13 |
EP1292302A2 (en) | 2003-03-19 |
AU2001268446B2 (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200300418B (en) | Method of treating cardiovascular disease. | |
GB0014969D0 (en) | Novel method of treatment | |
AU2001249881A1 (en) | Method of treating the heart | |
HK1035505A1 (en) | Method of confirming performer of exercise. | |
ZA200108446B (en) | Novel method of treatment. | |
GB0028264D0 (en) | Well treatment | |
ZA200308523B (en) | A method of microwave treatment of wood. | |
AU6485901A (en) | Method for providing enhanced blood circulation | |
AU2002215125A1 (en) | Well treatment method | |
GB0129976D0 (en) | Treatment method | |
EG23373A (en) | Process and intermediates. | |
MXPA03001717A (es) | METODO PARA EL TRATAMIENTO DE LA MIGRAnA. | |
MXPA03006607A (es) | Metodo combinado para tratar trastornos dependientes de hormonas. | |
GB0104879D0 (en) | Method of comparing parts | |
AP2004003070A0 (en) | The method of treating cancer. | |
MXPA03003347A (es) | Procedimiento para purificacion de pravastatina. | |
GB0120147D0 (en) | Treatment method | |
ZA200206252B (en) | Method and compositions for treating an inflammatory disease. | |
ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
MXPA03004017A (es) | Metodo para el tratamiento de inflamacion. | |
MXPA03005569A (es) | PROCEDIMIENTO MEJORADO PARA LA PREPARACION DE UN FARMACO ANTIMIGRAnOSO. | |
GB0026838D0 (en) | Treatment method | |
GB0008921D0 (en) | Method of treatment | |
ZA200210361B (en) | Method of administering bishosphonates. | |
GB0020910D0 (en) | Reduction method |